Hair loss treatment: Japan's Aderans signs deal with U.S. startup

TOKYO -- Japanese hair care company Aderans will grant intellectual property rights for its hair restoration research to a U.S. biotech startup, with an eye to future collaboration on treatments for pattern baldness and other conditions.

Aderans and California-based Stemson Therapeutics have reached a licensing agreement that provides exclusive use of the Japanese company's IP.